Alan Levy - Intuitive Surgical Insider

ISRG -- USA Stock  

USD 524.28  6.22  1.20%

Independent Director
Dr. Alan J. Levy, Ph.D. is Lead Independent Director of the Company. Dr. Levy was the Founder, Chairman and Chief Executive Officer of Chrono Therapeutics, a privatelyheld digital medicine company, from February 2014 to February 2018. From 2012 to 2017, he was a Senior Advisor at Frazier Healthcare Ventures, and also a Venture Partner from 2007 to 2012. From June 2010 to January 2013, he was the Chief Executive Officer of Incline Therapeutics, Inc., a novel drugdevice company that was acquired by the Medicines Company in 2013. He served as Chairman of the Board of Directors of Northstar Neuroscience, Inc., a medical device company he cofounded, from 2007 to 2009. Prior to that, he was the President and Chief Executive Officer of Northstar Neuroscience from 1999 to 2007. From 1993 to 1998, Dr. Levy served as President and Chief Executive Officer of Heartstream, Inc., a medical device company that was acquired by HewlettPackard in 1998. Prior to joining Heartstream, Inc., he was President of Heart Technology, Inc., a medical device company that was acquired by Boston Scientific in 1995. Before joining Heart Technology, Dr. Levy was Vice President of Research and New Business Development and a member of the Board of Directors of Ethicon, a division of Johnson Johnson. Dr. Levy holds a B.S. in Chemistry from City University of New York and a Ph.D. in Organic Chemistry from Purdue University. Dr. Levy currently serves as a director of several private companies and notforprofit organizations.
Age: 79  Director Since 2013      

Alan Levy Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 12.76 % which means that it generated profit of $12.76 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 15.91 % meaning that it created $15.91 on every $100 dollars invested by stockholders.

Similar Executives

Showing few of many executives


William KuchemanHill Rom Holdings
Peter PronovostCantel Medical Corp
Jack PeurachEkso Bionics Holdings
Dan BorenEkso Bionics Holdings
Alfred SommerBecton Dickinson and Company
William DempseyHill Rom Holdings
Thomas ZentyEndologix
Gary PetersmeyerThe Cooper Companies
Stanley SternEkso Bionics Holdings
Amy WendellEkso Bionics Holdings
Charles DockendorffHaemonetics Corporation
Marilyn HamiltonEkso Bionics Holdings
Blake DevittBaxter International
Nancy SchlichtingHill Rom Holdings
Ted WangEkso Bionics Holdings
Robert AbernathyHaemonetics Corporation
Bernhard SaxeDaxor Corporation
Ann BermanCantel Medical Corp
Marshall LarsenBecton Dickinson and Company
Willard OverlockBecton Dickinson and Company
Cathy SmithBaxter International

Entity Summary

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company was founded in 1995 and is headquartered in Sunnyvale, California. Intuitive Surgical operates under Medical Instruments Supplies classification in USA and traded on NASDAQ. It employs 4444 people.Intuitive Surgical (ISRG) is traded on BATS Exchange in USA. It is located in CALIFORNIA U.S.A and employs 4,444 people. Intuitive Surgical is listed under Medical Equipment category by Fama And French industry classification.

Intuitive Surgical Leadership Team

David Rosa, EVP
Mark Rubash, Director
Michael Friedman, Director, Ph.D
Jamie Samath, VP
Amal Johnson, Director
Craig Barratt, Director
Eric Halvorson, Director
Lonnie Smith, Chairman
Jami Nachtsheim, Director
Gary Guthart, CEO
Alan Levy, Director
Myriam Curet, President
Mark Meltzer, SVP
Colin Morales, President
Salvatore Brogna, EVP
George Stalk, Director
Keith Leonard, Director, MBA
Marshall Mohr, CFO

Stock Performance Indicators

Did you try this?

Run Transaction History Now

Transaction History

View history of all your transactions and understand their impact on performance
All  Next Launch Transaction History

Build Optimal Portfolios

Align your risk with return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Balance Of Power module to check stock momentum by analyzing balance of power indicator and other technical ratios.